Fulltext

Data on known anti-virals in combating CoVid-19

Akshayaa L 1 , Lakshmi T 1 , Devaraj E 1 , Roy A 1 , Raghunandhakumar S 1 , Sivaperumal P 1 Show all authors , David S 2 , Dua K 3 , Chellappan DK 4

Affiliations 

  • 1 Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai-600077, TamilNadu
  • 2 PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Brunei
  • 3 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia
  • 4 Department of Life sciences, School of Pharmacy, International Medical University ,Bukit Jalil, 57000, Kualalumpur, Malaysia
Bioinformation, 2020;16(11):878-881.
PMID: 34803262 DOI: 10.6026/97320630016878

Abstract

Design and development of effective anti-virals in combating CoVid-19 is a great challenge worldwide. Known drugs such as chloroquine, lopinavir, favipiravir and remdesivir are used in the management of CoVid - 19. It is known that Ivermectin and remdesivir both are effective against filoviruses, paramyxo viruses. Available data also shows that ivermectin and remedesivir repress the replication of SARS-CoV-2. Thus, we document the potential use of ivermectin and remdesivir in the management of CoVid -19.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications